fedratinib,momelotinib
gsk,bms
['mpnsm', 'momelotinib', '#mpn', 'fedra']
congress| #asco23 | , presents data from an itc safety analysis of momelotinib vs fedratinib in jaki-experienced/na ve pts with mf from phase 2 or 3 trials. momelotinib had a more favorable safety profile, with a lower risk of key hematologic aes
#mpnsm 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm